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Background:  Abacavir hypersensitivity syndrome (ABC HSR) is a potentially serious reaction 
occurring in 5% of those initiating the drug.   
Aim:  To examine the utility and safety of ABC patch testing (PT) and rechallenge in patients 
labeled with ABC HSR.   
Methods:  Patients with charts labeled as ABC HSR were identified and PT performed on 
consenting patients with petrolatum control, ABC 1% and ABC 10% and read at 24 hours. HLA-
typing was validated between two sites on consenting patients. Patients with negative 24 hour 
patch tests (PT-), with a clinical need for ABC were rechallenged with ABC 30 mg p.o. followed in 1 
hour by 300 mg p.o.  
Results: 15 patients labeled as ABC HSR identified to-date returned for patch testing. 2/15 (13.3%) 
were patch test positive (PT+) and 13/15 (86.7%) were PT- . 6/13 (46.1%) PT- patients were 
rechallenged with abacavir and 6/6 (100%) have tolerated ABC for a median of 12.5 (2-36) weeks.  
For 11 patients where genetic testing was available HLA-B*5701 was present in the 2/2 (100%) PT+ 
patients versus 0/9 patch PT- patients (p=0.018).   
Conclusions:  Clinical diagnosis of ABC HSR lacks precision as many more patients are labeled than 
have disease. PT is a potentially useful tool to identify true ABC HSR and appears to correlate well 
with genetic testing.  The potential for safe rechallenge of PT- patients who have a clinical need for 
ABC is intriguing but should currently be performed under close observation in a hospital research 
setting. 